首页 > 市场调查报告书 > 医疗设备

生技设备

市场调查报告书

商品编码

1818138

分子检测法市场报告：2031 年趋势、预测与竞争分析

Molecular Method Market Report: Trends, Forecast and Competitive Analysis to 2031

出版日期: 2025年09月19日 | 出版商:

Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录图表

全球分子检测法市场的未来在仪器、试剂和耗材以及服务市场中充满机会。预计2025年至2031年间，全球分子检测法市场的复合年增长率将达到6.1%。该市场的主要驱动力是个人化医疗需求的不断增长以及基因组学和生物技术研究的不断深入。

Lucintel 预测，在预测期内，聚合酵素链锁反应(PCR) 将在类型方面经历最高的成长。
按应用来看，试剂和耗材预计将达到最高成长。
按地区划分，预计亚太地区将在预测期内实现最高成长。

分子检测法市场的新趋势

随着技术进步和各行各业应用的不断拓展，分子检测法市场正在快速发展。多项发展正在重塑市场格局，提升诊断能力，并拓展分子检测法的应用范围。

人工智慧 (AI) 与分子诊断的整合：AI 正在透过提高数据分析和解读的准确性来革新分子诊断。当与 PCR 和 NGS 等分子方法结合使用时，AI 演算法可以识别基因数据中的模式，从而帮助更有效地诊断癌症和遗传性疾病等疾病。 AI 驱动的解决方案也被用于提高检测速度并减少人为错误，使医疗保健提供者能够做出更及时、更准确的决策。随着 AI 技术的不断发展，它很可能在分子诊断的革新中发挥关键作用。
新一代定序 (NGS) 的应用不断扩展：NGS 技术正从基因研究扩展到临床诊断，尤其是在肿瘤学、遗传学和罕见疾病领域。 NGS 能够实现更全面、更详细的基因分析，从而实现精准医疗。 NGS 平台日益经济实惠且易于获取，这促进了其在临床环境中的应用，有助于更早发现疾病并制定个人化治疗方案。随着基因数据量的不断增长，NGS 正成为分子诊断和治疗方案製定的重要工具。
照护现场分子诊断：随着快速现场侦测需求的增加，尤其是在新冠疫情期间，即时分子诊断的需求日益增长。这些可携式设备在农村和照护现场欠缺地区尤其有用，因为它们无需实验室即可提供即时检测和结果。即时分子诊断越来越多地用于感染疾病检测、基因检测和慢性病监测。分子诊断工具的小型化趋势使检测更加便捷且高效，从而推动了该领域的进一步成长。
CRISPR技术在分子诊断领域的进展：CRISPR基因编辑技术正在彻底改变分子诊断，使其能够更准确、更有效率地检测特定基因序列。研发人员正在开发基于CRISPR的诊断工具，以快速且准确地检测病原体和基因突变。这些进展有望改善早期疾病检测，并为个人化医疗提供潜在的解决方案。将CRISPR整合到分子诊断中是一个重要的趋势，它将带来更快、更便宜的诊断工具，惠及医疗保健和农业。
环境监测中的分子方法：分子方法在环境监测中的应用正在不断扩展，其应用范围从检测水中的病原体到识别土壤中的污染物。 PCR 和 NGS 正被用于检测饮用水中的微生物污染、评估生物多样性以及监测入侵物种的传播。这些方法有助于提高环境安全性和永续性，尤其是在气候变迁和环境恶化日益加剧的背景下。随着各国政府和组织更加重视更有效的环境监测和管理，分子方法在环境科学中的应用预计将会成长。

这些新兴趋势正在重塑分子检测法市场，推动创新，提高可及性，并扩大应用范围。人工智慧的整合、NGS的扩展、照护现场诊断、CRISPR技术的进步以及环境监测是将继续塑造市场的关键趋势。这些技术的进步将在医疗保健、农业和环境保护领域创造新的机会，从而改变全球各行各业。

分子检测法市场的最新趋势

随着技术的进步以及诊断和研究应用的不断扩大，一些关键的发展正在影响分子检测法市场。

快速PCR检测平台的开发：PCR技术的最新发展促进了更快、更准确的检测平台的开发。这些平台可以提供即时结果，这对于感染疾病诊断至关重要。 COVID-19疫情大大加速了快速PCR检测的普及，其应用范围目前正扩展到其他感染疾病和基因检测。
基于 CRISPR 的诊断工具的进展：基于 CRISPR 的分子诊断工具的开发代表了市场的一个重要里程碑。这些工具能够快速且准确地检测基因突变和病原体。 CRISPR 诊断可在数小时内完成，非常适合照护现场，并缩短医疗保健领域的诊断週转时间。
NGS 在临床诊断中的应用日益广泛：次世代定序仪(NGS) 的应用范围正在从研究扩展到临床诊断，尤其是在肿瘤学和罕见遗传疾病领域。 NGS 提供全面的基因洞察，从而製定更个人化的治疗方案。随着 NGS 成本的持续下降，它有望成为临床实践中的标准工具，提高诊断准确性和治疗效果。
永续农业的分子方法：分子方法正越来越多地被用于应对农业挑战，例如疾病检测、害虫管理和作物基因改造。用于检测植物病原体的分子诊断工具的开发提高了粮食安全。分子方法也被用于开发具有更强抗病虫害能力的基因改造作物，为永续农业做出贡献。
照护现场诊断的进展：照护现场(POC) 分子诊断设备的开发取得了重大进展，尤其是在感染疾病领域。这些可携式、易于使用的设备可实现现场检测，无需实验室。即时诊断的发展使分子检测在农村和资源匮乏地区更加普及，从而改善了全球的医疗保健成果。

这些关键发展正在透过提高诊断的速度、准确性和可及性来塑造分子检测市场。 PCR、CRISPR、NGS 和 POC 诊断领域的创新正在改变医疗保健和农业，使分子检测更加高效，并得到更广泛的应用。

The future of the global molecular method market looks promising with opportunities in the instrument, reagents & consumables, and services markets. The global molecular method market is expected to grow with a CAGR of 6.1% from 2025 to 2031. The major drivers for this market are the rising demand for personalized medicine and increased research in genomics and biotechnology.

Lucintel forecasts that, within the type category, polymerase chain reaction (PCR) is expected to witness the highest growth over the forecast period.
Within the application category, reagents & consumables are expected to witness the highest growth.
In terms of region, APAC is expected to witness the highest growth over the forecast period.

Emerging Trends in the Molecular Method Market

The molecular method market is evolving rapidly due to technological advancements and increasing applications in various industries. Several trends are reshaping the landscape, enhancing diagnostic capabilities, and expanding the scope of molecular methods.

Integration of Artificial Intelligence (AI) in Molecular Diagnostics: AI is transforming molecular diagnostics by improving the accuracy of data analysis and interpretation. In combination with molecular techniques like PCR and NGS, AI algorithms can identify patterns in genetic data, which aids in diagnosing diseases such as cancer and genetic disorders more effectively. AI-driven solutions are also being used to improve the speed of testing and reduce human error, enabling healthcare providers to make more timely and accurate decisions. As AI technologies continue to evolve, they will play a significant role in revolutionizing molecular diagnostics.
Expansion of Next-Generation Sequencing (NGS) Applications: NGS technologies are expanding beyond genetic research into clinical diagnostics, particularly in oncology, genetics, and rare diseases. NGS allows for more comprehensive and detailed genetic analysis, which enables precision medicine. The growing affordability and accessibility of NGS platforms are driving their use in clinical settings, facilitating early disease detection and personalized treatment plans. With the increasing volume of genetic data, NGS is becoming a key tool in molecular diagnostics and therapeutic decision-making.
Point-of-Care Molecular Diagnostics: The demand for point-of-care (POC) molecular diagnostics has been rising, especially in response to the need for rapid, on-site testing during the COVID-19 pandemic. These portable devices enable immediate testing and results without requiring a laboratory setting, which is particularly valuable in rural or underserved areas. POC molecular diagnostics are being increasingly used in infectious disease detection, genetic testing, and monitoring of chronic conditions. The trend toward miniaturization of molecular diagnostic tools is likely to drive further growth in this area, making testing more accessible and efficient.
Advancements in CRISPR Technology for Molecular Diagnostics: CRISPR gene-editing technology is revolutionizing molecular diagnostics by enabling more precise and efficient detection of specific genetic sequences. Researchers are developing CRISPR-based diagnostic tools that can quickly and accurately detect pathogens and genetic mutations. These advancements promise to improve early disease detection and offer potential solutions for personalized medicine. The integration of CRISPR into molecular diagnostics is a significant trend that could lead to faster and more affordable diagnostic tools, benefiting both healthcare and agriculture.
Molecular Methods in Environmental Monitoring: The use of molecular methods in environmental monitoring is growing, with applications ranging from detecting pathogens in water to identifying pollutants in soil. PCR and NGS are being used to detect microbial contamination in water supplies, assess biodiversity, and monitor the spread of invasive species. These methods are improving environmental safety and sustainability, particularly as concerns about climate change and environmental degradation increase. The adoption of molecular methods in environmental sciences is expected to grow as governments and organizations focus on more effective environmental monitoring and management.

These emerging trends are reshaping the molecular methods market by driving innovation, improving accessibility, and expanding the scope of applications. AI integration, NGS expansion, point-of-care diagnostics, CRISPR advancements, and environmental monitoring are key trends that will continue to shape the market. As these technologies advance, they will unlock new opportunities for healthcare, agriculture, and environmental protection, transforming industries worldwide.

Recent Developments in the Molecular Method Market

Several key developments are influencing the molecular method market, with technological advancements and growing applications in diagnostics and research.

Development of Rapid PCR Testing Platforms: Recent advancements in PCR technology have led to the development of faster and more accurate testing platforms. These platforms can deliver results in real-time, which is crucial for infectious disease diagnostics. The COVID-19 pandemic significantly accelerated the adoption of rapid PCR tests, and their application is now expanding to other infectious diseases and genetic testing.
Advancements in CRISPR-based Diagnostic Tools: The development of CRISPR-based molecular diagnostic tools is a significant milestone in the market. These tools allow for rapid and accurate detection of genetic mutations and pathogens. CRISPR diagnostics can be done in a matter of hours, making them ideal for use in point-of-care settings and reducing diagnostic turnaround times in healthcare.
Increased Use of NGS in Clinical Diagnostics: Next-generation sequencing (NGS) is expanding beyond research into clinical diagnostics, particularly in oncology and rare genetic disorders. NGS offers comprehensive genetic insights, enabling more personalized treatment plans. As the cost of NGS continues to decrease, it is expected to become a standard tool in clinical settings, improving diagnostic accuracy and treatment efficacy.
Molecular Methods for Sustainable Agriculture: Molecular methods are increasingly being used to address challenges in agriculture, including disease detection, pest management, and genetic modification of crops. The development of molecular diagnostic tools for detecting plant pathogens is improving food security. Molecular methods are also being employed to create genetically modified crops that are more resistant to pests and diseases, contributing to sustainable agriculture.
Advancements in Point-of-Care Diagnostic Devices: There has been a significant increase in the development of point-of-care (POC) molecular diagnostic devices, especially for infectious diseases. These portable and user-friendly devices enable on-site testing, eliminating the need for laboratory facilities. The growth of POC diagnostics is making molecular testing more accessible in rural and low-resource areas, improving global healthcare outcomes.

These key developments are shaping the molecular methods market by improving diagnostic speed, accuracy, and accessibility. Innovations in PCR, CRISPR, NGS, and point-of-care diagnostics are transforming healthcare and agriculture, making molecular methods more efficient and widely adopted.

Strategic Growth Opportunities in the Molecular Method Market

The molecular method market offers numerous growth opportunities across a variety of applications. As new technologies emerge, the potential for growth in healthcare, agriculture, and environmental monitoring expands.

Cancer Diagnostics and Treatment: Molecular methods are playing a key role in cancer diagnosis and treatment, with technologies such as PCR, NGS, and CRISPR being used to identify genetic mutations and biomarkers specific to various cancers. These tools enable early detection, personalized treatment, and better monitoring of treatment efficacy. The continued development of molecular methods in oncology presents significant growth opportunities.
Infectious Disease Detection and Monitoring: The demand for molecular methods in the detection and monitoring of infectious diseases has skyrocketed, particularly in response to the COVID-19 pandemic. PCR and other molecular techniques are becoming essential tools for diagnosing diseases like tuberculosis, HIV, and Zika virus. The growing need for rapid diagnostics and surveillance tools in infectious disease control offers significant market growth potential.
Agricultural Biotechnology: Molecular methods are being increasingly used in agriculture for disease detection, pest management, and crop improvement. The development of genetically modified crops and more efficient pest control methods is driving the use of molecular diagnostics in the agricultural sector. This presents significant opportunities for growth in agricultural biotechnology, particularly in developing countries where food security is a priority.
Personalized Medicine and Genomic Research: The move toward personalized medicine, where treatments are tailored to an individual's genetic profile, is driving growth in genomic research and diagnostics. Molecular methods such as NGS and CRISPR-based technologies are enabling more accurate diagnoses and targeted therapies. This growing field presents significant growth opportunities for companies developing molecular diagnostic tools.
Environmental Monitoring and Sustainability: As concerns about climate change and environmental degradation rise, molecular methods are being increasingly used for environmental monitoring. These methods help detect pollutants, monitor biodiversity, and track the spread of invasive species. The demand for molecular tools in environmental science and sustainability is expected to grow as environmental protection becomes a higher priority worldwide.

The molecular methods market offers strategic growth opportunities in various sectors, including healthcare, agriculture, and environmental monitoring. By focusing on applications such as cancer diagnostics, infectious disease detection, and sustainable agriculture, the molecular methods market is poised for continued expansion and innovation.

Molecular Method Market Driver and Challenges

The molecular methods market is influenced by technological, economic, and regulatory factors that drive growth and pose challenges.

The factors responsible for driving the molecular method market include:

1. Technological Advancements: Advances in molecular technologies like PCR, NGS, and CRISPR are driving the market by enabling more accurate and rapid diagnostics. These innovations enhance disease detection and treatment planning, particularly in oncology, infectious diseases, and genetics.

2. Increased Demand for Early Disease Detection: As healthcare systems prioritize early detection and prevention, molecular methods are in high demand. Technologies that enable early diagnosis of conditions like cancer, genetic disorders, and infectious diseases are seeing significant growth.

3. Personalized Medicine: Personalized medicine is driving the adoption of molecular methods by offering tailored treatment plans based on genetic and molecular profiles. Technologies like NGS and CRISPR are essential for delivering personalized therapies.

4. Expanding Applications in Agriculture: Molecular methods are increasingly being used in agriculture for pathogen detection, pest management, and the development of genetically modified crops. This shift toward molecular-based agriculture is driving growth in the sector.

5. Rising Healthcare Expenditure: Global increases in healthcare spending are contributing to the adoption of advanced diagnostic technologies, including molecular methods. As healthcare providers invest in state-of-the-art diagnostic tools, the market for molecular methods expands.

Challenges in the molecular method market are:

1. High Costs of Molecular Methods: The cost of advanced molecular methods, including PCR, NGS, and CRISPR, remains a barrier to adoption in many regions. High costs can limit access to these technologies, particularly in low-income areas.

2. Regulatory Hurdles: The complex and varied regulatory requirements across countries pose challenges for the market. Different approval processes for molecular diagnostic devices and treatments can delay product launches and market entry.

3. Limited Awareness and Education: In some regions, there is limited awareness of the benefits and capabilities of molecular methods. Educating healthcare professionals and the public about the value of these technologies is crucial to driving adoption.

The molecular methods market is driven by technological advancements, increased demand for early disease detection, and the rise of personalized medicine. However, challenges such as high costs, regulatory barriers, and limited awareness need to be addressed to unlock the full potential of the market. Overcoming these challenges will support the continued growth and widespread adoption of molecular methods.

List of Molecular Method Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies molecular method companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the molecular method companies profiled in this report include-

Qiagen
3M
Veredus Laboratories
Neogen Corporation
Thermo Fisher Scientific
Bio-Rad Laboratories
BioMerieux
Archerdx
Himedia Laboratories
Eurofins Scientific

Molecular Method Market by Segment

The study includes a forecast for the global molecular method market by type, application, and region.

Molecular Method Market by Type [Value from 2019 to 2031]:

Polymerase Chain Reaction (PCR)
Immunoassay
Biosensors
Microarray
Other

Molecular Method Market by Application [Value from 2019 to 2031]:

Instrument
Reagents & Consumables
Services

Molecular Method Market by Region [Value from 2019 to 2031]:

North America
Europe
Asia Pacific
The Rest of the World

Country Wise Outlook for the Molecular Method Market

The molecular methods market has seen significant advancements in recent years due to innovations in diagnostic tools, biotechnology, and research methodologies. These techniques are pivotal in numerous sectors, including healthcare, agriculture, and environmental science. As the demand for more accurate and rapid testing grows, the molecular methods market has expanded globally. The United States, China, Germany, India, and Japan are key players in this market, each contributing unique advancements and driving innovation in their respective regions. In this overview, we will explore the recent developments within these countries.

United States: In the United States, molecular methods, particularly PCR (polymerase chain reaction) and next-generation sequencing (NGS), continue to lead to advancements in genetic testing, diagnostics, and personalized medicine. The COVID-19 pandemic significantly boosted the demand for molecular diagnostics, accelerating innovation in the development of rapid testing solutions. Furthermore, the integration of AI and machine learning in molecular diagnostics is gaining traction, enabling better data interpretation and faster diagnoses. The U.S. is also focusing on expanding research into CRISPR gene editing techniques, which will significantly impact various fields, including agriculture and healthcare.
China: China is increasingly focusing on expanding its molecular method capabilities in both healthcare and agricultural sectors. The country has made significant strides in NGS and PCR technologies, particularly for the early detection of infectious diseases and genetic conditions. The Chinese government has also invested heavily in biotechnology research, aiming to improve diagnostics and healthcare infrastructure. Additionally, China is leading efforts to develop molecular methods for agricultural applications, including the detection of plant pathogens and the development of genetically modified crops, which could further boost food security and sustainability.
Germany: Germany is at the forefront of applying molecular methods in diagnostics and research, with significant contributions to PCR and NGS technologies. The country's strong biotech industry is driving innovations in molecular diagnostics, particularly in oncology and infectious diseases. Researchers in Germany are developing cutting-edge molecular tools to detect genetic mutations and markers associated with various cancers, enabling earlier detection and more effective treatments. Germany is also focusing on expanding its research in molecular biology for agricultural uses, including the development of sustainable farming practices through molecular methods.
India: The Indian molecular methods market is rapidly evolving, driven by the need for affordable diagnostic solutions and advancements in biotechnology. PCR technology is widely used for diagnosing infectious diseases, including tuberculosis and COVID-19. However, India still faces challenges with access to high-quality molecular diagnostic tools in rural areas. Efforts are being made to develop more cost-effective molecular testing platforms and expand access across the country. India is also focusing on the research and development of molecular methods for improving crop yield and pest management in agriculture.
Japan: Japan remains a leader in molecular research, particularly in healthcare and agriculture. The country is heavily investing in advancements in molecular diagnostic tools for early detection of diseases like cancer, Alzheimer's, and cardiovascular diseases. Japan's molecular biology research is advancing the use of gene-editing tools such as CRISPR-Cas9. Additionally, the country is making strides in molecular methods for enhancing food security by developing more robust crops and improving food safety through pathogen detection technologies. Japan's continued investments in biotechnology ensure its leadership in innovation of molecular methods.

Features of the Global Molecular Method Market

Market Size Estimates: Molecular method market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.
Segmentation Analysis: Molecular method market size by type, application, and region in terms of value ($B).
Regional Analysis: Molecular method market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different types, applications, and regions for the molecular method market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the molecular method market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

This report answers following 11 key questions:

Q.1. What are some of the most promising, high-growth opportunities for the molecular method market by type (polymerase chain reaction (PCR), immunoassay, biosensors, microarray, and other), application (instrument, reagents & consumables, and services), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

1. Executive Summary

2. Market Overview

2.1 Background and Classifications
2.2 Supply Chain

3. Market Trends & Forecast Analysis

3.1 Macroeconomic Trends and Forecasts
3.2 Industry Drivers and Challenges
3.3 PESTLE Analysis
3.4 Patent Analysis
3.5 Regulatory Environment

4. Global Molecular Method Market by Type

4.1 Overview
4.2 Attractiveness Analysis by Type
4.3 Polymerase Chain Reaction (PCR): Trends and Forecast (2019-2031)
4.4 Immunoassay: Trends and Forecast (2019-2031)
4.5 Biosensors: Trends and Forecast (2019-2031)
4.6 Microarray: Trends and Forecast (2019-2031)
4.7 Other: Trends and Forecast (2019-2031)

5. Global Molecular Method Market by Application

5.1 Overview
5.2 Attractiveness Analysis by Application
5.3 Instrument: Trends and Forecast (2019-2031)
5.4 Reagents & Consumables: Trends and Forecast (2019-2031)
5.5 Services: Trends and Forecast (2019-2031)

6. Regional Analysis

6.1 Overview
6.2 Global Molecular Method Market by Region

7. North American Molecular Method Market

7.1 Overview
7.2 North American Molecular Method Market by Type
7.3 North American Molecular Method Market by Application
7.4 United States Molecular Method Market
7.5 Mexican Molecular Method Market
7.6 Canadian Molecular Method Market

8. European Molecular Method Market

8.1 Overview
8.2 European Molecular Method Market by Type
8.3 European Molecular Method Market by Application
8.4 German Molecular Method Market
8.5 French Molecular Method Market
8.6 Spanish Molecular Method Market
8.7 Italian Molecular Method Market
8.8 United Kingdom Molecular Method Market

9. APAC Molecular Method Market

9.1 Overview
9.2 APAC Molecular Method Market by Type
9.3 APAC Molecular Method Market by Application
9.4 Japanese Molecular Method Market
9.5 Indian Molecular Method Market
9.6 Chinese Molecular Method Market
9.7 South Korean Molecular Method Market
9.8 Indonesian Molecular Method Market

10. ROW Molecular Method Market

10.1 Overview
10.2 ROW Molecular Method Market by Type
10.3 ROW Molecular Method Market by Application
10.4 Middle Eastern Molecular Method Market
10.5 South American Molecular Method Market
10.6 African Molecular Method Market

11. Competitor Analysis

11.1 Product Portfolio Analysis
11.2 Operational Integration
11.3 Porter's Five Forces Analysis
- Competitive Rivalry
- Bargaining Power of Buyers
- Bargaining Power of Suppliers
- Threat of Substitutes
- Threat of New Entrants
11.4 Market Share Analysis

12. Opportunities & Strategic Analysis

12.1 Value Chain Analysis
12.2 Growth Opportunity Analysis
- 12.2.1 Growth Opportunities by Type
- 12.2.2 Growth Opportunities by Application
12.3 Emerging Trends in the Global Molecular Method Market
12.4 Strategic Analysis
- 12.4.1 New Product Development
- 12.4.2 Certification and Licensing
- 12.4.3 Mergers, Acquisitions, Agreements, Collaborations, and Joint Ventures

13. Company Profiles of the Leading Players Across the Value Chain

13.1 Competitive Analysis
13.2 Qiagen
- Company Overview
- Molecular Method Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
13.3 3M
- Company Overview
- Molecular Method Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
13.4 Veredus Laboratories
- Company Overview
- Molecular Method Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
13.5 Neogen Corporation
- Company Overview
- Molecular Method Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
13.6 Thermo Fisher Scientific
- Company Overview
- Molecular Method Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
13.7 Bio-Rad Laboratories
- Company Overview
- Molecular Method Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
13.8 BioMerieux
- Company Overview
- Molecular Method Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
13.9 Archerdx
- Company Overview
- Molecular Method Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
13.10 Himedia Laboratories
- Company Overview
- Molecular Method Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
13.11 Eurofins Scientific
- Company Overview
- Molecular Method Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing

14. Appendix

14.1 List of Figures
14.2 List of Tables
14.3 Research Methodology
14.4 Disclaimer
14.5 Copyright
14.6 Abbreviations and Technical Units
14.7 About Us
14.8 Contact Us

简介目录图表

List of Figures

Figure 1.1: Trends and Forecast for the Global Molecular Method Market
Figure 2.1: Usage of Molecular Method Market
Figure 2.2: Classification of the Global Molecular Method Market
Figure 2.3: Supply Chain of the Global Molecular Method Market
Figure 3.1: Trends of the Global GDP Growth Rate
Figure 3.2: Trends of the Global Population Growth Rate
Figure 3.3: Trends of the Global Inflation Rate
Figure 3.4: Trends of the Global Unemployment Rate
Figure 3.5: Trends of the Regional GDP Growth Rate
Figure 3.6: Trends of the Regional Population Growth Rate
Figure 3.7: Trends of the Regional Inflation Rate
Figure 3.8: Trends of the Regional Unemployment Rate
Figure 3.9: Trends of Regional Per Capita Income
Figure 3.10: Forecast for the Global GDP Growth Rate
Figure 3.11: Forecast for the Global Population Growth Rate
Figure 3.12: Forecast for the Global Inflation Rate
Figure 3.13: Forecast for the Global Unemployment Rate
Figure 3.14: Forecast for the Regional GDP Growth Rate
Figure 3.15: Forecast for the Regional Population Growth Rate
Figure 3.16: Forecast for the Regional Inflation Rate
Figure 3.17: Forecast for the Regional Unemployment Rate
Figure 3.18: Forecast for Regional Per Capita Income
Figure 3.19: Driver and Challenges of the Molecular Method Market
Figure 4.1: Global Molecular Method Market by Type in 2019, 2024, and 2031
Figure 4.2: Trends of the Global Molecular Method Market ($B) by Type
Figure 4.3: Forecast for the Global Molecular Method Market ($B) by Type
Figure 4.4: Trends and Forecast for Polymerase Chain Reaction (PCR) in the Global Molecular Method Market (2019-2031)
Figure 4.5: Trends and Forecast for Immunoassay in the Global Molecular Method Market (2019-2031)
Figure 4.6: Trends and Forecast for Biosensors in the Global Molecular Method Market (2019-2031)
Figure 4.7: Trends and Forecast for Microarray in the Global Molecular Method Market (2019-2031)
Figure 4.8: Trends and Forecast for Other in the Global Molecular Method Market (2019-2031)
Figure 5.1: Global Molecular Method Market by Application in 2019, 2024, and 2031
Figure 5.2: Trends of the Global Molecular Method Market ($B) by Application
Figure 5.3: Forecast for the Global Molecular Method Market ($B) by Application
Figure 5.4: Trends and Forecast for Instrument in the Global Molecular Method Market (2019-2031)
Figure 5.5: Trends and Forecast for Reagents & Consumables in the Global Molecular Method Market (2019-2031)
Figure 5.6: Trends and Forecast for Services in the Global Molecular Method Market (2019-2031)
Figure 6.1: Trends of the Global Molecular Method Market ($B) by Region (2019-2024)
Figure 6.2: Forecast for the Global Molecular Method Market ($B) by Region (2025-2031)
Figure 7.1: Trends and Forecast for the North American Molecular Method Market (2019-2031)
Figure 7.2: North American Molecular Method Market by Type in 2019, 2024, and 2031
Figure 7.3: Trends of the North American Molecular Method Market ($B) by Type (2019-2024)
Figure 7.4: Forecast for the North American Molecular Method Market ($B) by Type (2025-2031)
Figure 7.5: North American Molecular Method Market by Application in 2019, 2024, and 2031
Figure 7.6: Trends of the North American Molecular Method Market ($B) by Application (2019-2024)
Figure 7.7: Forecast for the North American Molecular Method Market ($B) by Application (2025-2031)
Figure 7.8: Trends and Forecast for the United States Molecular Method Market ($B) (2019-2031)
Figure 7.9: Trends and Forecast for the Mexican Molecular Method Market ($B) (2019-2031)
Figure 7.10: Trends and Forecast for the Canadian Molecular Method Market ($B) (2019-2031)
Figure 8.1: Trends and Forecast for the European Molecular Method Market (2019-2031)
Figure 8.2: European Molecular Method Market by Type in 2019, 2024, and 2031
Figure 8.3: Trends of the European Molecular Method Market ($B) by Type (2019-2024)
Figure 8.4: Forecast for the European Molecular Method Market ($B) by Type (2025-2031)
Figure 8.5: European Molecular Method Market by Application in 2019, 2024, and 2031
Figure 8.6: Trends of the European Molecular Method Market ($B) by Application (2019-2024)
Figure 8.7: Forecast for the European Molecular Method Market ($B) by Application (2025-2031)
Figure 8.8: Trends and Forecast for the German Molecular Method Market ($B) (2019-2031)
Figure 8.9: Trends and Forecast for the French Molecular Method Market ($B) (2019-2031)
Figure 8.10: Trends and Forecast for the Spanish Molecular Method Market ($B) (2019-2031)
Figure 8.11: Trends and Forecast for the Italian Molecular Method Market ($B) (2019-2031)
Figure 8.12: Trends and Forecast for the United Kingdom Molecular Method Market ($B) (2019-2031)
Figure 9.1: Trends and Forecast for the APAC Molecular Method Market (2019-2031)
Figure 9.2: APAC Molecular Method Market by Type in 2019, 2024, and 2031
Figure 9.3: Trends of the APAC Molecular Method Market ($B) by Type (2019-2024)
Figure 9.4: Forecast for the APAC Molecular Method Market ($B) by Type (2025-2031)
Figure 9.5: APAC Molecular Method Market by Application in 2019, 2024, and 2031
Figure 9.6: Trends of the APAC Molecular Method Market ($B) by Application (2019-2024)
Figure 9.7: Forecast for the APAC Molecular Method Market ($B) by Application (2025-2031)
Figure 9.8: Trends and Forecast for the Japanese Molecular Method Market ($B) (2019-2031)
Figure 9.9: Trends and Forecast for the Indian Molecular Method Market ($B) (2019-2031)
Figure 9.10: Trends and Forecast for the Chinese Molecular Method Market ($B) (2019-2031)
Figure 9.11: Trends and Forecast for the South Korean Molecular Method Market ($B) (2019-2031)
Figure 9.12: Trends and Forecast for the Indonesian Molecular Method Market ($B) (2019-2031)
Figure 10.1: Trends and Forecast for the ROW Molecular Method Market (2019-2031)
Figure 10.2: ROW Molecular Method Market by Type in 2019, 2024, and 2031
Figure 10.3: Trends of the ROW Molecular Method Market ($B) by Type (2019-2024)
Figure 10.4: Forecast for the ROW Molecular Method Market ($B) by Type (2025-2031)
Figure 10.5: ROW Molecular Method Market by Application in 2019, 2024, and 2031
Figure 10.6: Trends of the ROW Molecular Method Market ($B) by Application (2019-2024)
Figure 10.7: Forecast for the ROW Molecular Method Market ($B) by Application (2025-2031)
Figure 10.8: Trends and Forecast for the Middle Eastern Molecular Method Market ($B) (2019-2031)
Figure 10.9: Trends and Forecast for the South American Molecular Method Market ($B) (2019-2031)
Figure 10.10: Trends and Forecast for the African Molecular Method Market ($B) (2019-2031)
Figure 11.1: Porter's Five Forces Analysis of the Global Molecular Method Market
Figure 11.2: Market Share (%) of Top Players in the Global Molecular Method Market (2024)
Figure 12.1: Growth Opportunities for the Global Molecular Method Market by Type
Figure 12.2: Growth Opportunities for the Global Molecular Method Market by Application
Figure 12.3: Growth Opportunities for the Global Molecular Method Market by Region
Figure 12.4: Emerging Trends in the Global Molecular Method Market

List of Tables

Table 1.1: Growth Rate (%, 2023-2024) and CAGR (%, 2025-2031) of the Molecular Method Market by Type and Application
Table 1.2: Attractiveness Analysis for the Molecular Method Market by Region
Table 1.3: Global Molecular Method Market Parameters and Attributes
Table 3.1: Trends of the Global Molecular Method Market (2019-2024)
Table 3.2: Forecast for the Global Molecular Method Market (2025-2031)
Table 4.1: Attractiveness Analysis for the Global Molecular Method Market by Type
Table 4.2: Market Size and CAGR of Various Type in the Global Molecular Method Market (2019-2024)
Table 4.3: Market Size and CAGR of Various Type in the Global Molecular Method Market (2025-2031)
Table 4.4: Trends of Polymerase Chain Reaction (PCR) in the Global Molecular Method Market (2019-2024)
Table 4.5: Forecast for Polymerase Chain Reaction (PCR) in the Global Molecular Method Market (2025-2031)
Table 4.6: Trends of Immunoassay in the Global Molecular Method Market (2019-2024)
Table 4.7: Forecast for Immunoassay in the Global Molecular Method Market (2025-2031)
Table 4.8: Trends of Biosensors in the Global Molecular Method Market (2019-2024)
Table 4.9: Forecast for Biosensors in the Global Molecular Method Market (2025-2031)
Table 4.10: Trends of Microarray in the Global Molecular Method Market (2019-2024)
Table 4.11: Forecast for Microarray in the Global Molecular Method Market (2025-2031)
Table 4.12: Trends of Other in the Global Molecular Method Market (2019-2024)
Table 4.13: Forecast for Other in the Global Molecular Method Market (2025-2031)
Table 5.1: Attractiveness Analysis for the Global Molecular Method Market by Application
Table 5.2: Market Size and CAGR of Various Application in the Global Molecular Method Market (2019-2024)
Table 5.3: Market Size and CAGR of Various Application in the Global Molecular Method Market (2025-2031)
Table 5.4: Trends of Instrument in the Global Molecular Method Market (2019-2024)
Table 5.5: Forecast for Instrument in the Global Molecular Method Market (2025-2031)
Table 5.6: Trends of Reagents & Consumables in the Global Molecular Method Market (2019-2024)
Table 5.7: Forecast for Reagents & Consumables in the Global Molecular Method Market (2025-2031)
Table 5.8: Trends of Services in the Global Molecular Method Market (2019-2024)
Table 5.9: Forecast for Services in the Global Molecular Method Market (2025-2031)
Table 6.1: Market Size and CAGR of Various Regions in the Global Molecular Method Market (2019-2024)
Table 6.2: Market Size and CAGR of Various Regions in the Global Molecular Method Market (2025-2031)
Table 7.1: Trends of the North American Molecular Method Market (2019-2024)
Table 7.2: Forecast for the North American Molecular Method Market (2025-2031)
Table 7.3: Market Size and CAGR of Various Type in the North American Molecular Method Market (2019-2024)
Table 7.4: Market Size and CAGR of Various Type in the North American Molecular Method Market (2025-2031)
Table 7.5: Market Size and CAGR of Various Application in the North American Molecular Method Market (2019-2024)
Table 7.6: Market Size and CAGR of Various Application in the North American Molecular Method Market (2025-2031)
Table 7.7: Trends and Forecast for the United States Molecular Method Market (2019-2031)
Table 7.8: Trends and Forecast for the Mexican Molecular Method Market (2019-2031)
Table 7.9: Trends and Forecast for the Canadian Molecular Method Market (2019-2031)
Table 8.1: Trends of the European Molecular Method Market (2019-2024)
Table 8.2: Forecast for the European Molecular Method Market (2025-2031)
Table 8.3: Market Size and CAGR of Various Type in the European Molecular Method Market (2019-2024)
Table 8.4: Market Size and CAGR of Various Type in the European Molecular Method Market (2025-2031)
Table 8.5: Market Size and CAGR of Various Application in the European Molecular Method Market (2019-2024)
Table 8.6: Market Size and CAGR of Various Application in the European Molecular Method Market (2025-2031)
Table 8.7: Trends and Forecast for the German Molecular Method Market (2019-2031)
Table 8.8: Trends and Forecast for the French Molecular Method Market (2019-2031)
Table 8.9: Trends and Forecast for the Spanish Molecular Method Market (2019-2031)
Table 8.10: Trends and Forecast for the Italian Molecular Method Market (2019-2031)
Table 8.11: Trends and Forecast for the United Kingdom Molecular Method Market (2019-2031)
Table 9.1: Trends of the APAC Molecular Method Market (2019-2024)
Table 9.2: Forecast for the APAC Molecular Method Market (2025-2031)
Table 9.3: Market Size and CAGR of Various Type in the APAC Molecular Method Market (2019-2024)
Table 9.4: Market Size and CAGR of Various Type in the APAC Molecular Method Market (2025-2031)
Table 9.5: Market Size and CAGR of Various Application in the APAC Molecular Method Market (2019-2024)
Table 9.6: Market Size and CAGR of Various Application in the APAC Molecular Method Market (2025-2031)
Table 9.7: Trends and Forecast for the Japanese Molecular Method Market (2019-2031)
Table 9.8: Trends and Forecast for the Indian Molecular Method Market (2019-2031)
Table 9.9: Trends and Forecast for the Chinese Molecular Method Market (2019-2031)
Table 9.10: Trends and Forecast for the South Korean Molecular Method Market (2019-2031)
Table 9.11: Trends and Forecast for the Indonesian Molecular Method Market (2019-2031)
Table 10.1: Trends of the ROW Molecular Method Market (2019-2024)
Table 10.2: Forecast for the ROW Molecular Method Market (2025-2031)
Table 10.3: Market Size and CAGR of Various Type in the ROW Molecular Method Market (2019-2024)
Table 10.4: Market Size and CAGR of Various Type in the ROW Molecular Method Market (2025-2031)
Table 10.5: Market Size and CAGR of Various Application in the ROW Molecular Method Market (2019-2024)
Table 10.6: Market Size and CAGR of Various Application in the ROW Molecular Method Market (2025-2031)
Table 10.7: Trends and Forecast for the Middle Eastern Molecular Method Market (2019-2031)
Table 10.8: Trends and Forecast for the South American Molecular Method Market (2019-2031)
Table 10.9: Trends and Forecast for the African Molecular Method Market (2019-2031)
Table 11.1: Product Mapping of Molecular Method Suppliers Based on Segments
Table 11.2: Operational Integration of Molecular Method Manufacturers
Table 11.3: Rankings of Suppliers Based on Molecular Method Revenue
Table 12.1: New Product Launches by Major Molecular Method Producers (2019-2024)
Table 12.2: Certification Acquired by Major Competitor in the Global Molecular Method Market

02-2729-4219

+886-2-2729-4219

License/价格

分子检测法市场报告：2031 年趋势、预测与竞争分析

Molecular Method Market Report: Trends, Forecast and Competitive Analysis to 2031

目录

第一章执行摘要

第二章 市场概况

第三章：市场趋势及预测分析

4. 全球分子检测法市场类型

5. 全球分子检测法市场（按应用）

第六章 区域分析

7. 北美分子检测法市场

8. 欧洲分子检测法市场

9. 亚太地区分子检测法市场

10. 世界其他地区分子检测法市场

第11章 竞争分析

第十二章：机会与策略分析

第十三章 价值链主要企业的公司简介

第十四章 附录